✦ LIBER ✦

PCN142 EVALUATION OF THE QUALITY OF LIFE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WHO FAILED TO FIRST LINE CHEMOTHERAPY IN TREATMENT WITH ERLOTINIB VS TAXANES

✍ Scribed by J Vargas; JD Gomez Rangel; L Martínez-Barrera; D Mendoza; Á Paladio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN34 PHARMAECONOMIC EVALUATION OF THE U

✍ C Tenorio; J Vargas; MI Pacheco; L González-Michaca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Randomized phase II study of gefitinib v

✍ Kim, Seung Tae; Uhm, Ji Eun; Lee, Jeeyun; Sun, Jong-mu; Sohn, Insuk; Kim, Seon W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB

9140 Evaluation of treatment adherence,

✍ Gebbia, V.; Russo, P.; Mancuso, G.; Arcara, C.; Borsellino, N. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9091 POSTER Quality of Life Assesment in

✍ Yalcin, B.; Suna, N.; Dogan, M.; Urun, Y.; Özdemir, N.; Gonullu, U.; Zengin, N.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A randomised phase II trial of docetaxel

✍ Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

PCN43 COST COMPARISON OF ERLOTINIB VERSU

✍ S Ravera; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB